Moderna, Inc. (MRNA)

103,29 +3,02 (+3,01%) Börsenschluss: 04:00PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 3.900

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Stephane Bancel	CEO & Director	4,97M	392,58M	1973
Dr. Stephen Hoge M.D.	Pres	2,41M	56,52M	1976
Mr. James M. Mock	Chief Financial Officer	1,49M	N/A	1977
Ms. Arpa Garay	Chief Commercial Officer	2,67M	N/A	1979
Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer	N/A	N/A	1966
Dr. Melissa J. Moore Ph.D.	Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Brad Miller	Chief Information Officer	N/A	N/A	1973
Ms. Lavina Talukdar CFA	Sr. VP & Head of Investor Relations	N/A	N/A	N/A
Ms. Shannon Thyme Klinger	Chief Legal Officer & Corp. Sec.	N/A	N/A	1971
Colleen Hussey	Sr. Director of Corp. Communications	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.s ISS Governance QualityScore, Stand 28. September 2023, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 10, Shareholderrechte: 10, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.